Canopy Rivers Portfolio Company Obtains Health Canada's R&D License To Develop Cannabis-Infused Beverages

Canopy Rivers Inc. RIV CNPOF said Tuesday its portfolio company Herbert Works Ltd. has obtained Health Canada’s research and development license to develop cannabis-infused beverages.

"This announcement represents a significant milestone for Herbert Works as the company continues to move quickly toward the development of exceptional and widely appealing THC-infused beverages," Narbe Alexandrian, President and CEO of Canopy Rivers said in a statement.

"It's a timely achievement, as the next wave of cannabis legalization in Canada will unlock these new product offerings in a matter of months. We believe that Herbert Works is in a prime position to capitalize on the growth opportunities that 'Cannabis 2.0' presents for consumers that are eager to try cannabis in different formats."

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Combining cannabis expertise and top-notch technology, Herbert Works creates products that answer to the consumer’s lifestyle needs.

Canopy Rivers is an investment platform that seeks investment opportunities in the cannabis industry. It owns 23% of the equity of Herbert Works on a diluted basis.

The company’s stock closed Monday at $1.87 per share.

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsHealth CanadaHerbert Works
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.